Pharmacology question(Expert oblige needed)?
From Mid 60's - Extensive research to measure correlations between neuroleptic-induced animal behavior and prediction of clinical effects.
A series of animal models beside the potential for predicting antipsychotic efficacy and side-effect liability emerged.
-Antagonism of low dose amphetamine or apomorphine-induced enhanced locomotor flurry as a n indicator of mesolimbic dopamine receptor(A10) neuronal blockade and presumably antipsychotic activity.
-Inhibition of high-ranking dose amphetamine or apomorphine-induced steretyped behavior(licking, gnawing, chewing) as a predictor of striatal dopamine receptor(A9) neuronal blockade and and so a measure of EPS liability associated beside antipsychotics.
My questions:
-What do locomotor leisure and EPS liability mean contained by this context?
-And what is this lecture slide chitchat about? Can anyone thoroughly explain so that i can figure out clearly?
Thank you!
Answers: uhm, i'm no expert (yet, hehe); i'm still reviewing for the local board exam, but i think, or i HOPE i can back a little...
the oration slide basically described how the research determined or "predicted" how "effective" (although forceful is not the right term per se) the antipsychotics be in blocking dopamine receptors by using animal models.
EPS is "extra-pyramidal side effects" of antipsychotics due to their blockage of dopamine, manifest through tremors, rigidity, tardive dyskinesia, parkinsonian-like symptoms, etc
in command to measure how disappointingly the antipsychotics caused EPS, the researchers used high-dose amphetamine or apomorphine, which are dopamine agonists, to induce licking, gnaw, chewing in the animals. the smaller quantity the animals exhibit such behavior, it means that the more the antipsychotic is competent to block striatal dopamine receptors which are the receptors associated with extrapyramidal effects. hence, they would know how to predict how liable the antipsychotic is in producing the undesirable EPS.
the researchers used low dose amphetamine or apomorphine to stimulate a10 receptors thereby inducing enhanced locomotor hobby (movement from place to place, basic movements, such as walking within humans). if this is again antagonized, it means that the mesolimbic dopamine receptors be indeed blocked, which is basically the machine of action of the antipsychotic.
this agency, the clinical effects, including the extent of EPS of the antipsychotics were predicted.
i am a bit rusty on this.
Apomorphine is a dopamine agonist, specifically it stimulates dopamine receptors.
Likewise, if a drug blocks dopamine, it is considered an antipsychotic or at least have that potential, as most antipsychotics block dopamine.
With regard to EPS, extrapyrmidal symptoms, we know that the unintended effects of antipsychotics is to block dopamine at the basal ganglion (located in the brain), principal to parkinson like side effects. It is not theraputic surrounded by terms of antipsychotic amusement, it is just another place contained by the brain, where you can detect dopamine blocking distraction by how the animal reacts.
If you tender amphetamine to a rat or mouse, in big enough dosage it starts to chew on its tail, and it is certain that people on amphetamines long ample and in glorious enough dosage tend to shift crazy, including self mutalation. Therefore, if you give a drug that blocks this manner in rats (the chewing of the tail) later that might indicated antispychotic activity (whether or not we know what receptors are involved.)
The pills and health information post by website user , ByeDR.com not guarantee correctness , is for informational purposes solitary and is not a substitute for medical advice or treatment for any medical conditions.
Related Questions and Answers